PRESS RELEASE published on 06/28/2023 at 09:01, 1 year 4 months ago Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
PRESS RELEASE published on 06/20/2023 at 09:01, 1 year 5 months ago Mainz BioMed N.V.: Mainz Biomed Expands into Romania Through Partnership with Bioclinica
PRESS RELEASE published on 05/31/2023 at 09:01, 1 year 5 months ago Mainz Biomed Expands Commercial Footprint into Poland
PRESS RELEASE published on 05/24/2023 at 09:01, 1 year 5 months ago Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper
PRESS RELEASE published on 05/16/2023 at 09:01, 1 year 6 months ago Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
PRESS RELEASE published on 05/10/2023 at 09:01, 1 year 6 months ago Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert
PRESS RELEASE published on 05/03/2023 at 09:00, 1 year 6 months ago Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners
PRESS RELEASE published on 05/01/2023 at 09:01, 1 year 6 months ago Mainz Biomed to Participate in Digestive Disease Week 2023
PRESS RELEASE published on 04/27/2023 at 09:01, 1 year 6 months ago Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
PRESS RELEASE published on 04/26/2023 at 09:01, 1 year 6 months ago Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
Published on 11/21/2024 at 22:05, 2 hours 4 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 19 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 54 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 59 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 4 hours 9 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:01, 5 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 33 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 10 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 17 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 17 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 17 hours 11 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
